Mounting Evidence Shows Red Wine Antioxidant Resveratrol Kills Cancer

Did you read todays headlines about the caner killing ability of resveratrol? Seems hardly a week goes by without hearing more news about the super antioxidant resveraltrol. But scientist do not recommend increasing alcohol consumption especially for women because of the increase or breast cancer recently linked to alcohol. You are far better off getting your reseveratrol from natural non toxic sources like grape juice. The problem with grape juice is it contains less reseveratrol than does red wine so one would have to drink large amounts and most fruit juices are high in calories and sugars which can pack extra weight on fast. A much better solution is "Kakadu Juice" because a 1oz or 30ml dosage contains as much resveratrol as 4 liters of red wine without high calories, sugar and the toxicity of alcohol.

If you didn't see the news today or headlines in your local newspaper you can catch up on the latest findings at: ScienceDaily (Mar. 27, 2008) — Rochester researchers showed for the first time that a natural antioxidant found in grape skins and red wine can help destroy pancreatic cancer cells by reaching to the cell's core energy source, or mitochondria, and crippling its function.

Resveratrol appears to kill off cancer cells by depolarizing (demagnetizing) mitochondrial bodies within tumor cells. Resveratrol is 100 anti-cancer drugs in one. Resveratrol works in so many ways to block cancer, researchers can’t find a cancer-promotion pathway it doesn’t inhibit. It is virtually non-toxic since, after oral ingestion, it is quickly metabolized by the liver, attached to a detoxification molecule called glucuronate, which renders it harmless, though biologically inactive, at least for a time.

At the site of tumors cells there is an unzipping enzyme (glucuronidase) that uncouples resveratrol from glucuronate. This is nature’s "drug delivery system," releasing resveratrol at the right time and place. This explains resveratrol’s stealthiness. [Cancer Letters 231: 113–22, 2006; Oncogene 23: 6702–11, 2004; Toxicology Letters 161: 1–9, 2006; World Journal Gastroenterology 12: 5628–34, 2006; Investigative Ophthalmology Visual Science 47: 3708–16, 2006; Cancer Detection Prevention 30: 217-23, 2006; Molecular Cancer Therapy 4: 554–61, 2005; Journal Biological Chemistry 278: 41482–90, 2003]